Miracle Mile Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $835K | Sell |
10,672
-577
| -5% | -$45.1K | 0.01% | 397 |
|
|
2025
Q1 | $815K | Buy |
11,249
+78
| +0.7% | +$5.65K | 0.02% | 357 |
|
|
2024
Q4 | $827K | Buy |
11,171
+509
| +5% | +$37.7K | 0.02% | 360 |
|
|
2024
Q3 | $704K | Buy |
10,662
+38
| +0.4% | +$2.51K | 0.02% | 320 |
|
|
2024
Q2 | $981K | Sell |
10,624
-254
| -2% | -$23.5K | 0.02% | 266 |
|
|
2024
Q1 | $1.04M | Buy |
10,878
+1,507
| +16% | +$144K | 0.03% | 267 |
|
|
2023
Q4 | $715K | Buy |
9,371
+1,074
| +13% | +$81.9K | 0.02% | 297 |
|
|
2023
Q3 | $575K | Hold |
8,297
| – | – | 0.02% | 308 |
|
|
2023
Q2 | $783K | Sell |
8,297
-899
| -10% | -$84.8K | 0.02% | 291 |
|
|
2023
Q1 | $761K | Buy |
9,196
+899
| +11% | +$74.4K | 0.02% | 313 |
|
|
2022
Q4 | $619K | Hold |
8,297
| – | – | 0.02% | 326 |
|
|
2022
Q3 | $686K | Buy |
8,297
+27
| +0.3% | +$2.23K | 0.03% | 247 |
|
|
2022
Q2 | $786K | Sell |
8,270
-4
| -0% | -$380 | 0.04% | 247 |
|
|
2022
Q1 | $974K | Sell |
8,274
-772
| -9% | -$90.9K | 0.04% | 239 |
|
|
2021
Q4 | $1.17M | Buy |
9,046
+14
| +0.2% | +$1.81K | 0.05% | 226 |
|
|
2021
Q3 | $1.02M | Sell |
9,032
-21
| -0.2% | -$2.38K | 0.05% | 221 |
|
|
2021
Q2 | $938K | Buy |
9,053
+767
| +9% | +$79.5K | 0.05% | 206 |
|
|
2021
Q1 | $693K | Sell |
8,286
-1,565
| -16% | -$131K | 0.04% | 227 |
|
|
2020
Q4 | $899K | Buy |
9,851
+2,603
| +36% | +$238K | 0.06% | 215 |
|
|
2020
Q3 | $579K | Buy |
+7,248
| New | +$579K | 0.04% | 230 |
|
|
2020
Q1 | – | Sell |
-2,934
| Closed | -$228K | – | 286 |
|
|
2019
Q4 | $228K | Buy |
2,934
+87
| +3% | +$6.76K | 0.02% | 273 |
|
|
2019
Q3 | $209K | Buy |
+2,847
| New | +$209K | 0.01% | 265 |
|